Hazlewood GS, Loyola-Sanchez A, Bykerk V, et al. - This study was attempted to evaluate the perspectives of patients and rheumatologists for tapering DMARDs in rheumatoid arthritis (RA). Researchers performed individual interviews and focus groups with RA patients and rheumatologists using semi-structured interview guides, which were audiotaped and transcribed. A pragmatic thematic analysis was performed to distinguish major themes, comparing and contrasting different views on DMARD tapering between patients and rheumatologists. A total of 28 adult patients with RA (64% women; disease duration 1–54 years) and 23 rheumatologists were included in the study (52% women). The outcomes suggested that the perspectives of patients and rheumatologists on tapering DMARDs in RA vary and evolve over time. It has been considered that Rheumatologists should periodically discuss DMARD tapering with patients as part of shared decision making, and ensure monitoring and flare management plans are in place.